|
01 Feb 2011 |
Bavarian Nordic Completes Smallpox Vaccine Phase 2 Trial in Vulnerable Population
|
|
01 Feb 2011 |
Circassia's ToleroMune(R) T-cell Vaccine Achieves Significant Reduction in Allergy Symptoms in Key Phase II Clinical Study
|
|
31 Jan 2011 |
Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV)
|
|
31 Jan 2011 |
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo, for use in children from 2 years of age
|
|
31 Jan 2011 |
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
|
|
25 Jan 2011 |
BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine
|
|
25 Jan 2011 |
Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
|
|
25 Jan 2011 |
GenVec and U.S. Naval Medical Research Center to Collaborate on Vaccine for Dengue Fever
|
|
24 Jan 2011 |
Northwest Biotherapeutics Resuming Enrollment In Promising 240-Patient Clinical Trial of DCVax for Brain Cancer
|
|
21 Jan 2011 |
Joint development of therapeutic cancer vaccine WT4869
|
|
14 Jan 2011 |
Independent Data Safety Monitoring Board Gives “Go-Ahead” to Complete Dosing in First Leg of Advaxis’ Phase II Cervical Dysplasia Trial
|
|
13 Jan 2011 |
Recipharm AB Announces Successful Pre-Clinical Tuberculosis Vaccine Results using its Oral Vaccine Delivery Platform
|
|
12 Jan 2011 |
Preclinical Efficacy of Inovio Pharmaceuticals’ Chikungunya DNA Vaccine Featured in PLoS Neglected Tropical Diseases
|
|
11 Jan 2011 |
Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results in Melanoma
|
|
10 Jan 2011 |
Inovio Pharmaceuticals’ Novel DNA Vaccine for Clade C HIV Achieves Immune Responses and Protection in Non-Human Primates
|
|
06 Jan 2011 |
Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
|
|
05 Jan 2011 |
Medicago announces Publication of its Phase I Study with its Pandemic H5N1 Influenza Virus-Like Particle (VLP) Vaccine Candidate
|
|
05 Jan 2011 |
Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
|
|
05 Jan 2011 |
Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin in Multiple Sclerosis
|
|
04 Jan 2011 |
ImmunoCellular Therapeutics Receives FDA Approval to Commence Phase II Trial of ICT-107
|
|
04 Jan 2011 |
NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)
|
|
28 Dec 2010 |
Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
|
|
28 Dec 2010 |
Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine
|
|
23 Dec 2010 |
Dynavax Reports Phase 1B Safety and Immunogenicity Results for Hepatitis B Therapy Candidate
|
|
23 Dec 2010 |
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL
|
